| Faton Bytyci, MD | |
|
450 Chew St, Suite 101, Allentown, PA 18102-3434 | |
| (610) 776-4888 | |
| (610) 776-4895 |
| Full Name | Faton Bytyci |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 450 Chew St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619380847 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MT206112 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Medical Of Upper East Side Pllc | 0648465039 | 759 |
News Archive
A high concentration of multi-strain probiotic helps to reduce mild to moderate episodes of chemotherapy-induced diarrhea in cancer patients, according to results of a phase II/III study in India.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).
The risk of developing breast cancer is doubled in women who inherit a damaged version of a gene called ATM, according to a study published by Cancer Research UK funded scientists and collaborators in Nature Genetics.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
› Verified 6 days ago
| Entity Name | City Medical Of Upper East Side Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801277629 PECOS PAC ID: 0648465039 Enrollment ID: O20101111000052 |
News Archive
A high concentration of multi-strain probiotic helps to reduce mild to moderate episodes of chemotherapy-induced diarrhea in cancer patients, according to results of a phase II/III study in India.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).
The risk of developing breast cancer is doubled in women who inherit a damaged version of a gene called ATM, according to a study published by Cancer Research UK funded scientists and collaborators in Nature Genetics.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Faton Bytyci, MD 450 Chew St, Suite 101, Allentown, PA 18102-3434 Ph: (610) 776-4888 | Faton Bytyci, MD 450 Chew St, Suite 101, Allentown, PA 18102-3434 Ph: (610) 776-4888 |
News Archive
A high concentration of multi-strain probiotic helps to reduce mild to moderate episodes of chemotherapy-induced diarrhea in cancer patients, according to results of a phase II/III study in India.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).
The risk of developing breast cancer is doubled in women who inherit a damaged version of a gene called ATM, according to a study published by Cancer Research UK funded scientists and collaborators in Nature Genetics.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
› Verified 6 days ago
Dr. Xander Arwand, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd Ste 110, Allentown, PA 18103 Phone: 610-402-8900 Fax: 610-402-5656 | |
John E Connelly, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 N 17th St, Suite # 108, Allentown, PA 18104 Phone: 610-434-4760 Fax: 610-820-9122 | |
Dr. Ann Marie Lam, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1251 S Cedar Crest Blvd, Suite 102 A, Allentown, PA 18103 Phone: 610-402-3940 Fax: 610-102-3950 | |
Leyland Robinson, Family Medicine Medicare: Medicare Enrolled Practice Location: 3435 Winchester Rd Ste 201, Allentown, PA 18104 Phone: 610-402-0100 | |
Dr. Joseph Thomas Termini, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 942 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-433-0404 | |
Madhavi Capoccia, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Cetronia Rd, Suite 115, Allentown, PA 18104 Phone: 610-395-0307 Fax: 610-395-0950 | |
Pavel Enrique Terreros, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1447 W Hamilton St, Allentown, PA 18102 Phone: 610-434-4445 |